X4 Pharmaceuticals Inc XFOR
News
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
X4 Pharmaceuticals to Participate in Upcoming September Investor Conferences
X4 Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
X4 Pharmaceuticals to Report Second Quarter 2024 Financial Results and Host a Conference Call and Webcast on August 8, 2024
X4 Pharmaceuticals Gets FDA Approval for Xolremdi Capsules